BIOMAT Database Logo BIOMAT Database Logo

The effect of adenosine on mitogenesis of ADA-deficient lymphocytes. 1978

J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
January 1977, Advances in experimental medicine and biology,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions.
September 1992, Blood,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Suppression of an antibody to adenosine-deaminase (ADA) in an ADA-deficient patient receiving polyethylene glycol modified adenosine deaminase.
June 1993, Annals of allergy,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Effect of some thiol reagents on erythrocyte adenosine deaminase (ADA) activity.
January 1988, Enzyme,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.
January 1991, Journal of inherited metabolic disease,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.
January 1991, Advances in experimental medicine and biology,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).
May 2017, Journal of clinical immunology,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
[Adenosine deaminase (ADA) deficiency, partial ADA deficiency].
January 1998, Ryoikibetsu shokogun shirizu,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: production of an ADA-deficient homozygote ES cell line.
July 1995, Transgenic research,
J Uberti, and J J Lightbody, and J W Wolf, and J A Anderson, and R H Reid, and R M Johnson
Increased purine nucleotides in adenosine deaminase-deficient lymphocytes.
July 1977, The Journal of pediatrics,
Copied contents to your clipboard!